Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge
- 1 April 2007
- journal article
- research article
- Published by BMJ in Tobacco Control
- Vol. 16 (2), 138-142
- https://doi.org/10.1136/tc.2006.018440
Abstract
Objective: To compare nicotine pharmacokinetics and subjective effects of three new smokeless tobacco potential reduced exposure products (PREPs; Ariva, Revel and Stonewall) with moist snuff (Copenhagen) and medicinal nicotine (Commit lozenge). Methods: 10 subjects completed a randomised, within-subject, crossover study. Subjects used one product for 30 min at each of the five laboratory sessions. Maximal nicotine concentration (Cmax) was determined and area under the concentration time curve (AUC) was calculated for a 90-min period (during use and 60 min after use). Nicotine craving, withdrawal symptoms and ratings of product effects and liking were measured during product use. Results: Nicotine AUC and Cmax were higher for Copenhagen than for any other product (pmax for Commit was also higher than for Stonewall (p = 0.03). Craving was lowest during use of Copenhagen (pConclusion: The new smokeless tobacco PREPs result in lower nicotine concentrations and equivalent or lower reductions in subjective measures compared with medicinal nicotine. Since health effects of PREPs are largely unknown, medicinal nicotine should be preferentially encouraged for smokers or smokeless tobacco users wishing to switch to lower-risk products.Keywords
This publication has 20 references indexed in Scilit:
- Tobacco‐specific nitrosamines in new tobacco productsNicotine & Tobacco Research, 2006
- Interventions for smokeless tobacco use cessationPublished by Wiley ,2004
- Evaluation of Carcinogen Exposure in People Who Used "Reduced Exposure" Tobacco ProductsJNCI Journal of the National Cancer Institute, 2004
- Smokeless tobacco use: harm reduction or induction approach?Preventive Medicine, 2004
- Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine contentNicotine & Tobacco Research, 2003
- Pharmacokinetics of a nicotine polacrilex lozengeNicotine & Tobacco Research, 2003
- Pharmacokinetics and pharmacodynamics of moist snuff in humansTobacco Control, 1999
- Physiologic and subjective changes from smokeless tobacco withdrawalClinical Pharmacology & Therapeutics, 1987
- Taste dimensions in cigarette discrimination: A multidimensional scaling approachAddictive Behaviors, 1986
- Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1981